All Insights and Resources

Collaborations, Mergers & Acquisitions

Castle Creek Bioscience Achieves $112.8 Million Financing to Advance Gene Therapies

26 May 2022

Castle Creek Bioscience Achieves $112.8 Million Financing to Advance Gene Therapies

The late-stage cell and gene

Umoja and Lupagen Collaboration Drives Improved Delivery for Next Generation <i data-src=

in vivo CAR-T" />

24 May 2022

Umoja and Lupagen Collaboration Drives Improved Delivery for Next Generation in vivo CAR-T

The immune-oncology company Umoja Biopharma,

Virica Biotech Receives Funding from Canadian Government to Support the Re-Development of the Worlds First Ever Gene Therapy

18 May 2022

Virica Biotech Receives Funding from Canadian Government to Support the Re-Development of the Worlds First Ever Gene Therapy

Virica Biotech has announced collaboration

A Fragmented Regulatory Landscape is No Thorn for EU Healthcare Growth

25 April 2022

A Fragmented Regulatory Landscape is No Thorn for EU Healthcare Growth

Phacilitate’s Wesley Johnson explores more top deals

POPULAR NEWS ITEMS

<img alt="Image" data-src="https://www.phacilitate.com/wp-content/themes/phacilitatewires/dist/images/140-140.png" class="lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" /><noscript><img alt="Image" data-src="https://www.phacilitate.com/wp-content/themes/phacilitatewires/dist/images/140-140.png" class="lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" /><noscript><img alt="Image" data-src="https://www.phacilitate.com/wp-content/themes/phacilitatewires/dist/images/140-140.png" class="lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" /><noscript><img alt="Image" data-src="https://www.phacilitate.com/wp-content/themes/phacilitatewires/dist/images/140-140.png" class="lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" /><noscript><img src="https://www.phacilitate.com/wp-content/themes/phacilitatewires/dist/images/140-140.png" alt="Image" />

26 May 2022

Castle Creek Bioscience Achieves $112.8 Million Financing to Advance Gene Therapies

<img alt="Image" data-src="https://www.phacilitate.com/wp-content/themes/phacilitatewires/dist/images/140-140.png" class="lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" /><noscript><img alt="Image" data-src="https://www.phacilitate.com/wp-content/themes/phacilitatewires/dist/images/140-140.png" class="lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" /><noscript><img alt="Image" data-src="https://www.phacilitate.com/wp-content/themes/phacilitatewires/dist/images/140-140.png" class="lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" /><noscript><img alt="Image" data-src="https://www.phacilitate.com/wp-content/themes/phacilitatewires/dist/images/140-140.png" class="lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" /><noscript><img src="https://www.phacilitate.com/wp-content/themes/phacilitatewires/dist/images/140-140.png" alt="Image" />

25 May 2022

Key Takeaways from ASGCT 2022

<img alt="Image" data-src="https://www.phacilitate.com/wp-content/themes/phacilitatewires/dist/images/140-140.png" class="lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" /><noscript><img alt="Image" data-src="https://www.phacilitate.com/wp-content/themes/phacilitatewires/dist/images/140-140.png" class="lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" /><noscript><img alt="Image" data-src="https://www.phacilitate.com/wp-content/themes/phacilitatewires/dist/images/140-140.png" class="lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" /><noscript><img alt="Image" data-src="https://www.phacilitate.com/wp-content/themes/phacilitatewires/dist/images/140-140.png" class="lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" /><noscript><img src="https://www.phacilitate.com/wp-content/themes/phacilitatewires/dist/images/140-140.png" alt="Image" />

24 May 2022

Umoja and Lupagen Collaboration Drives Improved Delivery for Next Generation in vivo CAR-T

Takeda to Explore Gene Therapy Applications of JCR’S J-Brain Cargo Technology

29 March 2022

Takeda to Explore Gene Therapy Applications of JCR’S J-Brain Cargo Technology

JCR Pharmaceuticals, a global specialty

FDA Approves Janssen’s CAR-T Cell Immunotherapy for Relapsed or Refectory Multiple Myeloma

1 March 2022

FDA Approves Janssen’s CAR-T Cell Immunotherapy for Relapsed or Refectory Multiple Myeloma

News

FDA Grants BCMA CAR-T Cell Therapy for the Treatment of R/R Multiple Myeloma Orphan Drug Designation

17 February 2022

FDA Grants BCMA CAR-T Cell Therapy for the Treatment of R/R Multiple Myeloma Orphan Drug Designation

News

Fancy Funding Dress Codes for Start-ups in Life Science

16 February 2022

Fancy Funding Dress Codes for Start-ups in Life Science

Blog

RECOMENDED TOPICS

Clinical Trials

Collaborations, Mergers & Acquisitions

Finance & Investment

Patient Access & Engagement

Regulatory & Standards

POPULAR NEWS ITEMS

<img alt="Image" data-src="https://www.phacilitate.com/wp-content/themes/phacilitatewires/dist/images/140-140.png" class="lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" /><noscript><img alt="Image" data-src="https://www.phacilitate.com/wp-content/themes/phacilitatewires/dist/images/140-140.png" class="lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" /><noscript><img alt="Image" data-src="https://www.phacilitate.com/wp-content/themes/phacilitatewires/dist/images/140-140.png" class="lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" /><noscript><img alt="Image" data-src="https://www.phacilitate.com/wp-content/themes/phacilitatewires/dist/images/140-140.png" class="lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" /><noscript><img src="https://www.phacilitate.com/wp-content/themes/phacilitatewires/dist/images/140-140.png" alt="Image" />

Castle Creek Bioscience Achieves $112.8 Million Financing to Advance Gene Therapies

<img alt="Image" data-src="https://www.phacilitate.com/wp-content/themes/phacilitatewires/dist/images/140-140.png" class="lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" /><noscript><img alt="Image" data-src="https://www.phacilitate.com/wp-content/themes/phacilitatewires/dist/images/140-140.png" class="lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" /><noscript><img alt="Image" data-src="https://www.phacilitate.com/wp-content/themes/phacilitatewires/dist/images/140-140.png" class="lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" /><noscript><img alt="Image" data-src="https://www.phacilitate.com/wp-content/themes/phacilitatewires/dist/images/140-140.png" class="lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" /><noscript><img src="https://www.phacilitate.com/wp-content/themes/phacilitatewires/dist/images/140-140.png" alt="Image" />

Key Takeaways from ASGCT 2022

<img alt="Image" data-src="https://www.phacilitate.com/wp-content/themes/phacilitatewires/dist/images/140-140.png" class="lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" /><noscript><img alt="Image" data-src="https://www.phacilitate.com/wp-content/themes/phacilitatewires/dist/images/140-140.png" class="lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" /><noscript><img alt="Image" data-src="https://www.phacilitate.com/wp-content/themes/phacilitatewires/dist/images/140-140.png" class="lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" /><noscript><img alt="Image" data-src="https://www.phacilitate.com/wp-content/themes/phacilitatewires/dist/images/140-140.png" class="lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" /><noscript><img src="https://www.phacilitate.com/wp-content/themes/phacilitatewires/dist/images/140-140.png" alt="Image" />

Umoja and Lupagen Collaboration Drives Improved Delivery for Next Generation in vivo CAR-T

logo_mobile_footer

Company

Resources

Network

Clarion Events Limited is registered in England and Wales, Company Number 00454826, VAT No. GB 843845601 Registered Office: Bedford House, 69-79 Fulham High Street, London, SW6 3JW, United Kingdom.

Phacilitate is a part of Clarion Events Limited. © Phacilitate 2022